Chitinase-1 inhibition reverses metabolic dysregulation and restores homeostasis in MASH animal models
OATD-01 is a chitinase-1 (CHIT1) inhibitor, reducing inflammation and fibrosis in animal models where chronic inflammation leads to tissue remodeling. CHIT1, predominantly secreted by macrophages, is overexpressed in metabolic-dysfunction-associated steatohepatitis (MASH). In this study, we demonstrated the efficacy of OATD-01 in two murine and a rat model of MASH. RNA-Seq analysis revealed that OATD-01 reversed MASH-dysregulated genes. Apart from the attenuation of inflammation and fibrosis, OATD-01 regulated metabolic processes such as lipid metabolism and glycolysis. We demonstrated that both genetic and pharmacological inactivation of CHIT1 resulted in inhibition of glycolysis and glucose uptake in primary macrophages. As a consequence, we observed increased ATP, lower citrate and increased acetate levels, resulting in a reduced IL-1{beta} secretion. These results revealed the key role for CHIT1 in regulating metabolism. OATD-01 is a macrophage modulator that can directly restore metabolic balance and consequently inhibit inflammation and fibrosis, supporting its use for MASH treatment.